Chantal Bader studied pharmacy at the Ruprecht-Karls-University in Heidelberg. In 2016, she joined Rolf Müllers group at the HIPS, where she received her diploma for her thesis on bioactivity-guided isolation and structure elucidation of novel natural products from myxobacteria. After receiving her approbation in 2016, Chantal continued her research in Rolf Müllers group, where she currently works as a PhD student.
Chantal Bader’s work mainly focuses on method development for myxobacterial metabolomics. This includes evaluating the impact of state-of-the-art analytical techniques like FT-ICR and UHPLC-timsTOF for expanding the scope of detectable metabolites. For the isolation, characterization and de novo structure elucidation of novel natural products, she is also working with supercritical-fluid extraction and chromatography (SFE/SFC), as well as reversed-phase chromatography and high resolution NMR-spectroscopy.